RightAnswer Knowledge Solutions Search Results for infliximab

New Search  |  Search Results (infliximab)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp


All Other Data Sources:

DART Documentshelp
HSDB® Data Bankhelp
LOLI® Listingshelp
REPROTOX® Documentshelp
RTECS® Registryhelp
Shepard's Cataloghelp
TERIS Documentshelp
MSDSonline®help

ChemID External Links:


Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for infliximab:


Please note: this is an extract of information from a larger document. Full document and details are available by subscription.

ACUTE EXPOSURE INFORMATION

  1. WITH THERAPEUTIC USE
    1. COMMON - Abdominal pain, fatigue, and headache. SERIOUS - CV: acute coronary syndrome, worsening congestive heart failure. Hematologic: leukopenia, neutropenia, pancytopenia, thrombocytopenia. Hepatic: hepatotoxicity (rare). Immunologic: drug-induced lupus erythematosus, delayed immune hypersensitivity reaction, opportunistic infection, hepatosplenic T-cell lymphoma (rare). Neurologic: demyelinating disease of central nervous system. Respiratory: tuberculosis. Other: histoplasmosis, mycosis, sepsis.
  1. WITH POISONING/EXPOSURE
    1. Data are limited. Clinical effects are anticipated to be an extension of the adverse effects seen with therapeutic use.
© 2011-2017 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.